Able Labs Raises $8.7M Series A

Quoin Pharmaceuticals

Founded in 2018, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities, and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others. The company plans to establish a sales infrastructure to commercialize its products in both U.S. and Europe and seeks to enter into strategic licensing partnerships for all other territories. We are dedicated to finding unique solutions for rare and orphan indications and will continue to expand our pipeline of products to address the unmet needs of underserved patient populations. To learn more about Quoin Pharmaceuticals please visit our website: www.quoinpharma.com

Naria

Did you know the avg. U.S. child spends more than 7.5 hours per day on a screen! Instead of just consuming content, what if kids could use that time to create, imagine, and grow? That’s exactly what we’re building—guilt-free screen time that sparks creativity. Naria turns your imagination into reality. It's literal magic, well at least kids think so.

Beinsure ⭐

Beinsure.com is a global B2B digital media and market intelligence platform with 3M+ annual readers across key global insurance markets, focused on insurance, reinsurance, InsurTech, cyber risk, AI, blockchain, SaaS technologies, and investment trends shaping the future of risk markets. The platform was founded by entrepreneur and angel investor Oleg Parashchak. Since 2006, Beinsure has delivered insurance news, market research, rankings, expert analysis, funding insights, technology reviews, and data-driven intelligence for insurers, reinsurers, brokers, founders, investors, analysts, and decision-makers. The platform was relaunched in 2022 as a global insurance & InsurTech research hub. Beinsure is ranked among the leading trade insurance and InsurTech media platforms by audience, including insurance executives, reinsurers, brokers, startup founders, investors, risk managers, compliance leaders, technology providers, cybersecurity professionals. Beinsure covers insurance, reinsurance, InsurTech, AI in insurance, cyber insurance, risk management, blockchain, SaaS, underwriting technology, claims innovation, insurance analytics, market rankings, funding activity, M&A, regulation, and global risk trends. Our mission is to make complex insurance and technology topics clear, practical, and useful. We focus on structured analysis, transparent data, trusted rankings, independent market insight, and professional content that helps readers understand how risk, capital, regulation, and technology are changing insurance markets. Beinsure combines digital media, market analytics, audience intelligence, and data-driven research to support better decision-making across the insurance, reinsurance, InsurTech, and financial technology sectors. Between 2022 and 2026, Beinsure raised $1M across Pre-Seed ($200K) and Seed ($800K) rounds led by Finance Media and reached an $11M valuation, with participation from angel investor Oleg Parashchak.